LEONARDI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 179
EU - Europa 158
AS - Asia 46
AF - Africa 2
Totale 385
Nazione #
US - Stati Uniti d'America 179
IE - Irlanda 52
IT - Italia 41
SE - Svezia 24
CN - Cina 23
AT - Austria 20
SG - Singapore 18
FI - Finlandia 6
GB - Regno Unito 5
BE - Belgio 3
DE - Germania 3
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
IR - Iran 2
MK - Macedonia 2
PK - Pakistan 2
KZ - Kazakistan 1
Totale 385
Città #
Dublin 52
Chandler 45
Ashburn 26
Boardman 19
Shanghai 18
Vienna 16
Parma 14
Chicago 13
Singapore 12
Ann Arbor 7
Helsinki 6
Princeton 5
Graz 4
New York 4
Brussels 3
London 3
Abidjan 2
Beijing 2
Borås 2
Bremen 2
Houston 2
Karak 2
Liberty Lake 2
Milan 2
Milton Keynes 2
Neviano degli Arduini 2
Novellara 2
Rosate 2
Skopje 2
Vicopisano 2
Almaty 1
Ardabil 1
Brno 1
Dallas 1
Des Moines 1
Fremont 1
Los Angeles 1
Miami 1
Olomouc 1
Ozzano dell'Emilia 1
Taiyuan 1
Washington 1
Wilmington 1
Zanjan 1
Totale 289
Nome #
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 88
Stage III and metastatic Lymph Node Ratio are the only independent prognostic factors in colorectal signet-ring cell carcinoma patients 75
Should patients on levothyroxine therapy be screened for pancreatic cancer? 51
It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 36
Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 33
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review 30
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 29
Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study 28
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study (Drugs in R&D, (2017), 17, 4, (585-596), 10.1007/s40268-017-0209-5) 28
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals 8
Totale 406
Categoria #
all - tutte 2.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 11 0 11 7 2 0 0 2 2
2021/202223 0 1 2 0 1 0 7 1 1 0 1 9
2022/2023205 10 28 9 15 10 19 6 18 66 4 11 9
2023/2024106 8 7 6 3 7 19 9 7 1 8 9 22
2024/202537 17 11 9 0 0 0 0 0 0 0 0 0
Totale 406